Skip to main content
OpenTrials
Completed

NCT Number: NCT00592930

Olanzapine in the Treatment of Anorexia Nervosa

This study compared 10 weeks of treatment with olanzapine versus placebo in adolescent females with anorexia nervosa-restricting type who were undergoing acute treatment on an inpatient unit or a day hospital program that specializes in the treatment of eating disorders.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anorexia Nervosa Feeding and Eating Disorders Mental Disorders

Age range

12 year–23 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Schneider Children's Hospital

New Hyde Park, New York, 11040, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females, ages 12-23

Exclusion criteria

  • Binge-purge type

Treatment and study plan

Olanzapine

Drug

flexibly dosed oral olanzapine 2.5 to 15 mg/day

Placebo

Drug

Primary outcomes

  1. weight gain

    Time frame: 10 weeks

Secondary outcomes

  1. measures of psychiatric symptoms

    Time frame: 10 weeks

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Northwell Health

Other

Collaborators

  • Eli Lilly and Company

Registry information

Official study title

Pilot Study of the Efficacy of Olanzapine in the Treatment of Anorexias Nervosa

Important dates

Study start
2000
Primary completion
2004
Study completion
2004
First posted
Jan 14, 2008
Registry last updated
Jan 14, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.